OQG
20 FDA 510(k) clearances · Product code
144 daysmedian time to decision
414 days90th percentile
20clearances measured
FDA profile
- Official device name
- Hip Prosthesis, Semi-Constrained, Cemented, Metal/Polymer, + Additive, Porous, Uncemented
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 888.3358
- Medical specialty
- Orthopedic
- Flags
- Implant
- FDA definition
- 1. Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis. 2. Rheumatoid arthritis. 3. Correction of functional deformity. 4. Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques. 5. Revision procedures where other treatment or devices have failed. Cemented and uncemented use.
- Adverse events (MAUDE)
- 2020: 178 · 2021: 88 · 2022: 32 · 2023: 18 · 2024: 20 · 2026: 17
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
Track OQG automatically
Every clearance here is in the API, with alerts when new ones post.